Adjuvant pertuzumab (PER) for HER2-positive early stage breast cancer (eBC): A Swiss experience

Details

Request a copyRequest a copy
Serval ID
serval:BIB_7F2F9C828B3A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Production externe
Title
Adjuvant pertuzumab (PER) for HER2-positive early stage breast cancer (eBC): A Swiss experience
Journal
European Journal of Cancer
Author(s)
Stravodimou A., Bodmer A., Aedo Lopez V., Zurcher J.P., Zaman K.
ISSN
0959-8049
Publication state
Published
Issued date
04/2018
Volume
92
Pages
S93
Language
english
Keywords
Cancer Research, Oncology
DOI
10.1016/s0959-8049(18)30508-2
Create date
19/09/2021 21:31
Last modification date
20/09/2021 6:41
Usage data